These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Frequency of hemorrhagic complications in plasmapheresis without extracorporeal circuit anticoagulation, in children. Fernández Sarmiento J; Varela MA; Pinzón CE Transfus Apher Sci; 2016 Aug; 55(1):136-40. PubMed ID: 27177490 [TBL] [Abstract][Full Text] [Related]
6. [A comparative and technical assessment of the HELP system (heparin extracorporeal LDL precipitation) and cascade filtration (CF) for the treatment of high plasma lipids]. Loschiavo C G Ital Nefrol; 2013; 30(3):. PubMed ID: 23832475 [TBL] [Abstract][Full Text] [Related]
7. Quo vadis haemapheresis. Current developments in haemapheresis. Borberg H Transfus Apher Sci; 2006 Feb; 34(1):51-73. PubMed ID: 16412691 [TBL] [Abstract][Full Text] [Related]
8. Immunoadsorption, current status and future developments. Braun N; Bosch T Expert Opin Investig Drugs; 2000 Sep; 9(9):2017-38. PubMed ID: 11060790 [TBL] [Abstract][Full Text] [Related]
9. Blood detoxification by membrane plasma filtration. Malchesky PS; Horiuchi T; Usami M; Emura M; Nose Y Int J Artif Organs; 1986 Sep; 9(5):349-54. PubMed ID: 3781668 [TBL] [Abstract][Full Text] [Related]
10. A novel approach to the treatment of chronic fluid overload with a new plasma separation device. Ronco C; Ricci Z; Bellomo R; Bedogni F; Handley H; Gorsuch R; Levin N Cardiology; 2001; 96(3-4):202-8. PubMed ID: 11805388 [TBL] [Abstract][Full Text] [Related]
11. LDL-apheresis with the HELP system: a 16-month study in severe hypercholesterolemic patients with ischemic heart disease. Baggio G; Previato L; Corti C; Bilato C; Belloni M; Ongaro G; Crepaldi G Beitr Infusionsther; 1988; 23():146-51. PubMed ID: 2484770 [No Abstract] [Full Text] [Related]
13. [Beneficial characteristics of protease inhibitor as an anticoagulant for extracorporeal circulation]. Akizawa T Rinsho Ketsueki; 1990 Jun; 31(6):782-6. PubMed ID: 2214168 [TBL] [Abstract][Full Text] [Related]
14. Russian pioneers of therapeutic hemapheresis and extracorporeal hemocorrection: 100-year anniversary of the world's first successful plasmapheresis. Sokolov AA; Solovyev AG Ther Apher Dial; 2014 Apr; 18(2):117-21. PubMed ID: 24571429 [TBL] [Abstract][Full Text] [Related]
15. Plasmapheresis and other extracorporeal filtration techniques in critical patients. Daga Ruiz D; Fonseca San Miguel F; González de Molina FJ; Úbeda-Iglesias A; Navas Pérez A; Jannone Forés R Med Intensiva; 2017 Apr; 41(3):174-187. PubMed ID: 28062169 [TBL] [Abstract][Full Text] [Related]
16. Practical considerations for planning a therapeutic apheresis procedure. Shelat SG Am J Med; 2010 Sep; 123(9):777-84. PubMed ID: 20541168 [TBL] [Abstract][Full Text] [Related]
17. Are selective macromolecule removal plasmapheresis systems useful for autoimmune diseases or hyperlipidemia? Malchesky PS; Kaplan A; Koo AP; Sakurada Y; Siami GA ASAIO J; 1993; 39(4):868-72. PubMed ID: 8123919 [TBL] [Abstract][Full Text] [Related]
18. [Extracorporeal methods for low-density lipoprotein apheresis in treating patients with severe forms of hereditary hypercholesterolemia. A review]. Konovalov GA Ter Arkh; 1991; 63(10):111-9. PubMed ID: 1805407 [No Abstract] [Full Text] [Related]
19. Correction of hyperviscosity by apheresis. Zarkovic M; Kwaan HC Semin Thromb Hemost; 2003 Oct; 29(5):535-42. PubMed ID: 14631553 [TBL] [Abstract][Full Text] [Related]